GCG and type 2 diabetes mellitus: To provide proof of concept for the use of glucagon antagonism in diabetes, Brand et al. (17) normalized blood glucose of mildly alloxan diabetic rabbits (a type 2 diabetes–like model) by administration of a high-affinity monoclonal glucagon antibody, which could effectively neutralize circulating glucagon activity.